A Study of LY3337641 in Rheumatoid Arthritis (RAjuvenate)

I8K-MC-JPDA -

The main purpose of this study is to evaluate the safety and effectiveness of LY3337641 in adults with rheumatoid arthritis (RA).

Trial Summary

Age Range
18 - 65 years
Conditions the trial is for
What the trial is testing?
Could I receive a Placebo?
Yes
Enrollment Goal
286
Trial Dates
Aug 22, 2016 - Aug 15, 2018
How long will I be in the trial?
Your participation could last up to 10 weeks for Part A or up to 18 weeks for Part B.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.